MEUSW News and Press, 23andMe Holding Co. Warrant From 01/19/23

Summary NVTA Q4 cash balance remained flat year-over-year at $555M, with 2022 revenue declining by $4M to $122M. Shares appreciated 25% after last week's Q4 purview on optimism over management's ability to trim operating costs, which would provide NVTA with sufficient runway to execute ...

23andMe Holding Co. (ME) Q2 2023 Earnings Conference Call November 07, 2022 04:30 PM ET Company Participants Wade Walke - Vice President-Investor Relations Anne Wojcicki - Chief Executive Officer & Co-Founder Joe Selsavage - Interim Chief Financial Officer &a...

23andMe Holding Co. (ME) Q1 2023 Earnings Conference Call August 08, 2022 04:30 PM ET Company Participants Wade Walke - Vice President, Investor Relations Anne Wojcicki - Chief Executive Officer & Co-Founder Steve Schoch - Chief Financial Officer Kenneth ...

23andMe Holding Co. (ME) Q4 2022 Earnings Conference Call May 26, 2022 04:30 PM ET Company Participants Wade Walke - Vice President of Investor Relations Anne Wojcicki - Co-Founder and Chief Executive Officer Kenneth Hillan - Chief Therapeutics Officer Steve Schoch - Chief Financial Officer C...

23andMe Holding Co. (ME) Q3 2022 Earnings Conference Call February 10, 2022 16:30 ET Company Participants Wade Walke - Vice President of Investor Relations Anne Wojcicki - Co-Founder & Chief Executive Officer Steve Schoch - Chief Financial Officer Kenneth Hillan - Head of Therapeutics Con...

David Einhorn's 13F stock portfolio value decreased from $1.59B to $1.49B this quarter. Greenlight increased The ODP Group, LivaNova plc, and Sonos while reducing Concentrix and AerCap Holdings. The largest three positions are at ~44% of the portfolio. As of Q3 2021, the overall p...

23andMe Holding Co. (ME) Q2 2021 Earnings Conference Call November 10, 2021, 16:30 ET Company Participants Wade Walke - VP, IR Anne Wojcicki - Co-Founder, CEO, President & Director Steven Schoch - Chief Financial & Accounting Officer Kenneth Hillan - Head, Therapeutics Conference Call...

23andMe Holding Co. (ME) Q1 2022 Earnings Conference Call August 13, 2021 11:00 AM ET Company Participants Wade Walke – Vice President-Investor Relations Anne Wojcicki – Co-Founder and Chief Executive Officer Steve Schoch – Chief Financial Officer Kenneth Hillan – ...